Last reviewed · How we verify
NCT07145710
Raw Banana Flour-Enriched Muffins for Hypertensive Patients
NA trial testing Whole wheat muffin in Hypertension (HTN) in 42 participants. Completed in 20 October 2024.
18 October 2024
Quick facts
| Lead sponsor | University of Lahore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 42 |
| Start date | 8 August 2024 |
| Primary completion | 18 October 2024 |
| Estimated completion | 20 October 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Whole wheat muffin
- Whole wheat muffin enriched with raw banana flour (RBF) (contains 17.5g RBF)
- Whole wheat muffin enriched with raw banana flour (RBF) (contains 20g RBF)
Conditions studied
- Hypertension (HTN) — all drugs for Hypertension (HTN) →
- Lipid Profile — all drugs for Lipid Profile →
- Liver Enzymes — all drugs for Liver Enzymes →
Sponsor
University of Lahore
Who can join
Adults 35 to 55, any sex, with Hypertension (HTN) or Lipid Profile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluated the effects of raw banana flour (RBF)-enriched muffins on hypertensive patients in Lahore, Pakistan. A total of 34 patients were divided into three groups: a control group and two intervention groups receiving muffins with 35% (C1) or 40% (C2) RBF for 10 weeks. Sensory evaluation showed high acceptability of the 35% RBF muffins, comparable to control muffins. Clinical outcomes indicated that both intervention groups experienced improvements in body weight, BMI, blood pressure, liver enzymes, and lipid profiles, with more pronounced benefits observed in the 40% RBF group. The findings suggest that RBF-enriched muffins, particularly at 40% substitution, can offer functional, nutritional, and clinical benefits for individuals with hypertension.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07145710
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension (HTN)
Currently open trials in the same condition.
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
- NCT07357272 — A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment · recruiting
- NCT07380022 — Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Def · NA · recruiting
- NCT07067632 — To Study the Mortality Outcome of Controlled Blood Pressure Participants · active not recruiting
- NCT07130539 — Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hyperten · NA · active not recruiting
Other University of Lahore trials
Trials by the same sponsor.
- NCT07420244 — Task-oriented Training Versus Group Circuit Training in Children With Quadriplegic Cerebral Palsy · NA · not yet recruiting
- NCT07446218 — Pharmacist-led Interventions in Psychiatric Patients · NA · not yet recruiting
- NCT07359378 — Progressive Resistance Exercise Versus Functional Training in Elderly With Risk of Fall. · NA · not yet recruiting
- NCT07244913 — Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization in Chronic Non-specific Low Ba · NA · recruiting
- NCT07436624 — Kabat Rehabilitation Versus Kinesiology Taping in Bell's Palsy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07145710 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lahore
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07145710.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing